• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伦敦东部移民中幽门螺杆菌对甲硝唑耐药的高流行率:与既往硝基咪唑暴露及胃十二指肠疾病的关系

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease.

作者信息

Banatvala N, Davies G R, Abdi Y, Clements L, Rampton D S, Hardie J M, Feldman R A

机构信息

Department of Epidemiology and Medical Statistics, London Hospital Medical College, QMW.

出版信息

Gut. 1994 Nov;35(11):1562-6. doi: 10.1136/gut.35.11.1562.

DOI:10.1136/gut.35.11.1562
PMID:7828973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1375612/
Abstract

A high prevalence of metronidazole resistance in Helicobacter pylori is reported in developing countries. This study examined whether migrants referred for diagnostic gastroscopy at a United Kingdom centre (n = 54), had a higher prevalence of metronidazole resistance than subjects born in the United Kingdom attending endoscopy (n = 46). Records of nitroimidazole treatment prescribed in the United Kingdom was obtained in 83 patients to find out if there was an association between H pylori metronidazole resistance and previous ingestion of either metronidazole or tinidazole. The prevalence of metronidazole resistant isolates varied according to country of birth: Bangladesh (90%, 27 of 30), other countries (67%, 16 of 24), and United Kingdom (37%, 17 of 46) (p < 0.001). Among those born in the United Kingdom, women were more likely to harbour resistant H pylori than men (54% v 18% respectively, p = 0.01) and more likely to have a history of previous nitroimidazole ingestion (41% v 11% respectively, p = 0.02). Patients previously exposed to either metronidazole or tinidazole were more likely to harbour resistant strains (84% (27 of 32) v 41% (21 or 51), p < 0.0001). The distribution of gastroduodenal disease, assessed endoscopically, was not affected by metronidazole resistance status.

摘要

据报道,发展中国家幽门螺杆菌对甲硝唑的耐药率很高。本研究调查了在英国一家中心接受诊断性胃镜检查的移民(n = 54),其甲硝唑耐药率是否高于在英国出生并接受内镜检查的受试者(n = 46)。获取了83例患者在英国开具的硝基咪唑治疗记录,以确定幽门螺杆菌对甲硝唑的耐药性与之前服用甲硝唑或替硝唑之间是否存在关联。甲硝唑耐药菌株的流行率因出生国家而异:孟加拉国(90%,30例中的27例)、其他国家(67%,24例中的16例)和英国(37%,46例中的17例)(p < 0.001)。在出生于英国的人中,女性比男性更有可能携带耐药幽门螺杆菌(分别为54%和18%,p = 0.01),并且更有可能有既往硝基咪唑摄入史(分别为41%和11%,p = 0.02)。既往接触过甲硝唑或替硝唑的患者更有可能携带耐药菌株(84%(32例中的27例)对41%(51例中的21例),p < 0.0001)。通过内镜评估的胃十二指肠疾病分布不受甲硝唑耐药状态的影响。

相似文献

1
High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease.伦敦东部移民中幽门螺杆菌对甲硝唑耐药的高流行率:与既往硝基咪唑暴露及胃十二指肠疾病的关系
Gut. 1994 Nov;35(11):1562-6. doi: 10.1136/gut.35.11.1562.
2
Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.在澳大利亚消化不良患者的一个大型国际化队列中,幽门螺杆菌对甲硝唑耐药的患病率及人口统计学决定因素。
Aust N Z J Med. 1998 Oct;28(5):633-8. doi: 10.1111/j.1445-5994.1998.tb00660.x.
3
Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.1991年欧洲一项关于幽门螺杆菌对甲硝唑耐药性的多中心调查结果。幽门螺杆菌抗生素敏感性欧洲研究小组。
Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):777-81.
4
Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong.香港地区中国消化性溃疡病患者及正常对照人群中甲硝唑耐药幽门螺杆菌菌株的流行情况。
Gut. 1996 May;38(5):675-8. doi: 10.1136/gut.38.5.675.
5
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.抗生素敏感性在预测奥美拉唑、克拉霉素和替硝唑根除幽门螺杆菌失败中的相关性。
J Gastroenterol. 1998;33 Suppl 10:62-5.
6
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.使用奥美拉唑、克拉霉素和甲硝唑或奥硝唑进行为期一周的治疗,随后使用奥美拉唑进行3周治疗,根除幽门螺杆菌的效果相同,且能治愈十二指肠溃疡。
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1185-9.
7
High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.儿童幽门螺杆菌菌株对甲硝唑和克拉霉素的高耐药水平。
J Clin Microbiol. 2001 Jan;39(1):394-7. doi: 10.1128/JCM.39.1.394-397.2001.
8
Susceptibility of Helicobacter pylori to metronidazole.幽门螺杆菌对甲硝唑的敏感性。
Am J Gastroenterol. 2003 Oct;98(10):2157-61. doi: 10.1111/j.1572-0241.2003.07681.x.
9
Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients.消化不良患者中幽门螺杆菌对阿莫西林和甲硝唑敏感性的评估。
Ital J Gastroenterol. 1993 Feb-Mar;25(2):65-7.
10
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.克拉霉素和甲硝唑的高水平双重耐药以及左氧氟沙星对治疗失败患者幽门螺杆菌分离株的体外活性。
Int J Antimicrob Agents. 2004 Nov;24(5):433-8. doi: 10.1016/j.ijantimicag.2004.02.032.

引用本文的文献

1
The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.益生菌在根除幽门螺杆菌中的作用及对消化性溃疡治疗的总体影响:一项针对孟加拉国接受三联疗法患者的研究
Cureus. 2024 Mar 16;16(3):e56283. doi: 10.7759/cureus.56283. eCollection 2024 Mar.
2
diagnosis and therapy in the era of antimicrobial stewardship.抗菌药物管理时代的诊断与治疗
Therap Adv Gastroenterol. 2021 Dec 21;14:17562848211064080. doi: 10.1177/17562848211064080. eCollection 2021.
3
Antibiotic dispensation rates among participants in community-driven health research projects in Arctic Canada.北极加拿大社区驱动健康研究项目参与者中的抗生素配给率。
BMC Public Health. 2019 Jul 15;19(1):949. doi: 10.1186/s12889-019-7193-3.
4
Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan.巴基斯坦临床厌氧分离株对甲硝唑和碳青霉烯类药物的药敏性。
Antimicrob Resist Infect Control. 2019 Jun 14;8:99. doi: 10.1186/s13756-019-0549-8. eCollection 2019.
5
Primary antibiotic resistance and its relationship with cagA and vacA genes in Helicobacter pylori isolates from Algerian patients.阿尔及利亚患者幽门螺杆菌分离株中的原发性抗生素耐药性及其与cagA和vacA基因的关系。
Braz J Microbiol. 2018 Jul-Sep;49(3):544-551. doi: 10.1016/j.bjm.2017.11.003. Epub 2018 Feb 13.
6
Helicobacter pylori in bottled mineral water: genotyping and antimicrobial resistance properties.瓶装矿泉水中的幽门螺杆菌:基因分型及抗菌药物耐药特性
BMC Microbiol. 2016 Mar 12;16:40. doi: 10.1186/s12866-016-0647-1.
7
Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing.幽门螺杆菌抗生素耐药机制及分子检测。
Front Mol Biosci. 2014 Oct 24;1:19. doi: 10.3389/fmolb.2014.00019. eCollection 2014.
8
Helicobacter pylori infection in India from a western perspective.从西方视角看印度的幽门螺杆菌感染。
Indian J Med Res. 2012 Oct;136(4):549-62.
9
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.从突尼斯消化性溃疡和胃炎患者中分离的幽门螺杆菌对克拉霉素、甲硝唑和阿莫西林的原发性耐药:一项前瞻性多中心研究。
Ann Clin Microbiol Antimicrob. 2010 Aug 13;9:22. doi: 10.1186/1476-0711-9-22.
10
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.含佐剂的口服灭活全细胞幽门螺杆菌疫苗在有或无亚临床感染志愿者中的安全性和免疫原性
Infect Immun. 2001 Jun;69(6):3581-90. doi: 10.1128/IAI.69.6.3581-3590.2001.

本文引用的文献

1
Over the counter drugs in Bangladesh.孟加拉国的非处方药。
BMJ. 1993 Nov 27;307(6916):1422. doi: 10.1136/bmj.307.6916.1422-a.
2
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.脂多糖在铜绿假单胞菌对非通透性型氨基糖苷类抗生素耐药性中的变化。
Antimicrob Agents Chemother. 1984 Aug;26(2):250-5. doi: 10.1128/AAC.26.2.250.
3
Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content.通过培养、酶谱和蛋白质含量对“幽门弯曲菌”进行鉴定。
J Clin Microbiol. 1985 Dec;22(6):1007-10. doi: 10.1128/jcm.22.6.1007-1010.1985.
4
Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains.铜绿假单胞菌菌株对环丙沙星耐药变体的毒力降低
J Antimicrob Chemother. 1987 Dec;20(6):825-9. doi: 10.1093/jac/20.6.825.
5
Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo.鼠伤寒沙门氏菌强毒株的孔蛋白和ompR突变体的特性:ompR突变体在体内减毒。
Infect Immun. 1989 Jul;57(7):2136-40. doi: 10.1128/iai.57.7.2136-2140.1989.
6
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.十二指肠溃疡的治愈与幽门螺杆菌的根除相关。
Lancet. 1990 May 26;335(8700):1233-5. doi: 10.1016/0140-6736(90)91301-p.
7
Metronidazole resistance in Helicobacter pylori.幽门螺杆菌对甲硝唑的耐药性
Lancet. 1990 Apr 21;335(8695):976-7. doi: 10.1016/0140-6736(90)91043-a.
8
Metronidazole-resistant Helicobacter pylori.甲硝唑耐药的幽门螺杆菌
Lancet. 1990 Mar 3;335(8688):539-40. doi: 10.1016/0140-6736(90)90772-w.
9
Role of metronidazole resistance in therapy of Helicobacter pylori infections.甲硝唑耐药在幽门螺杆菌感染治疗中的作用。
Antimicrob Agents Chemother. 1992 Jan;36(1):163-6. doi: 10.1128/AAC.36.1.163.
10
Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)产生的肠毒素和溶血素的比较
J Med Microbiol. 1992 Mar;36(3):164-71. doi: 10.1099/00222615-36-3-164.